世界*实验材料供应商 AnaSpec 上海金畔生物为其中国代理， AnaSpec 在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， AnaSpec 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
AnaSpec 中国代理, AnaSpec 上海代理， AnaSpec 北京代理，AnaSpec 广东代理， AnaSpec 江苏代理AnaSpec 湖北代理,AnaSpec 天津,AnaSpec 黑龙江代理,AnaSpec 内蒙古代理,AnaSpec 吉林代理,AnaSpec 福建代理, AnaSpec 江苏代理, AnaSpec 浙江代理, AnaSpec 四川代理,
AnaSpec公司（美国）是蛋白质组学研究和生产领域的业界，该公司很早就获得了GMP药物生产的CDA及FDA认证，长期以来一直为科研工作者提供各种产品和相关服务。AnaSpec公司提供种类齐全的各类产品, 包括合成肽，用于多肽合成和药物研制的组合化学试剂, 荧光试剂, 氨基酸, 抗体, 生物素试剂, 检测试剂盒及其它附件。现已经被比利时eurogentec收购。
AnaSpec公司不仅供应产品，而且还根据客户需要提供各种服务，服务内容包括客户所需抗体生产, 客户所需染料合成, 以及客户试剂盒的设计和演示服务。在连续12年向各药厂和研究所提供产品和服务的过程中，AnaSpec公司由于不断的创新和对产品质量的严格要求而获得了良好的声誉。
1、合成肽（Peptides）产品：
b-amyloids
MOGs
HCV substrates
fluorescent labeled peptides
phosphopeptides
2、多肽检测试剂和抗体（Peptide Detection Reagents & Antibodies）产品：
fluorescent reagents
antibodies
biotin reagents
assay kits
3、组合化学试剂（Combinatorial Chemistry）产品：
a wide range of combinatorial chemistry products that are applicable to peptide synthesis and drug discovery
酶检测试剂
肽键的蛋白水解切割是影响蛋白质性质和功能的zui重要机制之一。蛋白酶普遍存在于所有组织和生物液体中。它们在蛋白质活化，细胞调节和信号传导中发挥重要作用。它们也在产生蛋白质合成氨基酸或用于其他代谢途径中发挥作用。
AnaSpec提供世界上zui广泛的显色和荧光底物之一，可用于分析您的靶蛋白酶和抑制剂。这些包括胱天蛋白酶，MMP，分泌酶和病毒蛋白酶如HIV和HCV的选择性蛋白酶底物。我们的EnzoLyte™蛋白酶分析试剂盒为分析蛋白酶活性和筛选蛋白酶抑制剂提供了速度，方便性和准确性。为了进一步满足您对蛋白酶研究的具体需求，我们为您感兴趣的任何蛋白酶提供有竞争力的定制合成和测定设计。
部分产品信息如下：
|
货号 |
品名 |
规格 |
|
AS-25259-5 |
Caspase 1 (ICE) Substrate 2, chromogenic |
5 mg |
|
|
Ac – YVAD – pNA |
|
|
AS-25263-5 |
Caspase 3 (Apopain) Substrate 1, chromogenic |
5 mg |
|
|
Ac – DEVD – pNA |
|
|
AS-25258-5 |
Caspase 8 Substrate 1, chromogenic |
5 mg |
|
|
Ac – IETD – pNA |
|
|
AS-25278-5 |
Caspase 9 Substrate 1, chromogenic |
5 mg |
|
|
Ac – LEHD – pNA |
|
|
AS-25285-5 |
Caspase 1 (ICE) Substrate 3f, fluorogenic |
5 mg |
|
|
Ac – WEHD – AFC |
|
|
AS-25273-5 |
Caspase 3 (Apopain) Substrate 1f, fluorogenic |
5 mg |
|
|
Ac – DEVD – AFC |
|
|
AS-21685-5 |
Z – DEVD – AFC |
5 mg |
|
AS-25270-5 |
Caspase 8 Substrate 1f, fluorogenic |
5 mg |
|
|
Ac – IETD – AFC |
|
|
AS-25276-5 |
Caspase 9 Substrate 1f, fluorogenic |
5 mg |
|
|
Ac – LEHD – AFC |
|
|
AS-25262-5 |
Caspase 3 (Apopain) Substrate 1m, fluorogenic |
5 mg |
|
|
Ac – DEVD – AMC |
|
|
AS-60304-5 |
Caspase 3 (Apopain) Substrate 1r – z, fluorogenic |
5 mg |
|
|
(Z – DEVD)2 – Rh110 |
|
|
AS-85102 |
Collagen (Type I), FITC conjugated *Water Insoluble* |
5 mg |
|
AS-85103 |
Elastin, FITC – Conjugated *Water Insoluble* |
1 mg |
|
AS-24478 |
Renin FRET Substrate I |
1 mg |
|
AS-60320-5 |
(Z – AA)2Rh110 |
5 mg |
|
|
(Z – AA)2Rh110 |
|
|
AS-60321-5 |
(Z – Ala – Ala – Ala – Ala)2Rh110 |
5 mg |
|
|
(Z – AAAA)2Rh110 |
|
|
AS-60322-5 |
(Z – Arg)2Rh110 • 2HCl |
5 mg |
|
|
(Z – Arg)2Rh110 • 2HCl |
|
|
AS-60323-5 |
(Z – Arg)2Rh110 • 2HCl |
5 mg |
|
|
(Z – R)2Rh110 • 2HCl |
|
|
AS-85600 |
FDG |
5 mg |
|
|
[Fluorescein di – 尾 – D – galactopyranoside] |
|
|
AS-85617 |
Resorufin 尾 – D – Galactopyranoside |
25 mg |
|
AS-85618 |
4 – Nitrophenyl – N – acetyl – b – D – galactosaminide |
100 mg |
|
AS-85500 |
ADHP |
25 mg |
|
|
10 – Acetyl – 3,7 – dihydroxyphenoxazine |
|
|
AS-85706 |
2',7' – Dichlorodihydrofluorescein diacetate |
100 mg |
|
|
H2DCFDA, H2DCF DA |
|
|
AS-85711 |
Dihydrorhodamine 123 |
10 mg |
|
AS-85715 |
Ethoxyresorufin |
5 mg |
|
|
[Resorufin ethyl ether] |
|
|
AS-85707 |
Methoxyresorufin |
5 mg |
|
|
[Resorufin methyl ether] |
|
|
AS-82250 |
D – Luciferin, free acid *UltraPure Grade* |
25 mg |
|
AS-82252 |
D – Luciferin, potassium salt *UltraPure Grade* |
25 mg |
|
AS-85111 |
Collagen (Type I), FITC conjugated *Water Soluble* |
1 mg |
|
AS-85112 |
Collagen (Type IV), FAM conjugated |
1 mg |
|
AS-85113 |
Elastin, FITC Conjugated |
1 mg |
|
AS-85145 |
Gelatin, FITC Conjugated |
5 mg |
|
AS-27094 |
360 MMP FRET Substrate III |
1 mg |
|
|
Dnp – PLGMWSR |
|
|
AS-27076 |
390 MMP FRET Substrate I |
1 mg |
|
|
Mca – PLGL – Dpa – AR – NH2 |
|
|
AS-27077 |
390 MMP FRET Substrate I |
5 mg |
|
|
Mca – PLGL – Dpa – AR – NH2 |
|
|
AS-27079 |
390 MMP FRET Substrate II |
5 mg |
|
|
Mca – PLGL – Dpa – AR |
|
|
AS-27109 |
390 MMP FRET Substrate IV |
5 mg |
|
|
Mca – P – Cha – G – Nva – HA – Dpa – NH2 |
|
|
AS-27104 |
490 MMP FRET Substrate III |
1 mg |
|
|
DABCYL – RPLALWRS – EDANS |
|
|
AS-60584-01 |
5 – FAM MMP FRET Peptide Fluorescence Standard I |
0.1 mg |
|
|
5 – FAM – PL |
|
|
AS-60568-01 |
520 MMP FRET Substrate I |
0.1 mg |
|
|
QXL庐聽520 – PLGLWArK(5 – FAM) – NH2 |
|
|
AS-60570-01 |
520 MMP FRET Substrate III |
0.1 mg |
|
|
QXL® 520 – PLGC(Me)HAr – K(5 – FAM) – NH2 |
|
|
AS-60576-01 |
520 MMP FRET Substrate IX |
0.1 mg |
|
|
QXL® 520 – RPLALWRK(5 – FAM) – NH2 |
|
|
AS-60572-01 |
520 MMP FRET Substrate V |
0.1 mg |
|
|
5 – FAM – PLGL – Dap(QXL® 520) – AR – NH2 |
|
|
AS-60573-01 |
520 MMP FRET Substrate VI |
0.1 mg |
|
|
QXL® 520 – PLGMWSRK(5 – FAM) – NH2 |
|
|
AS-60574-01 |
520 MMP FRET Substrate VII |
0.1 mg |
|
|
QXL® 520 – PYAYWMRK(5 – FAM) – NH2 |
|
|
AS-60578-01 |
520 MMP FRET Substrate XI |
0.1 mg |
|
|
5 – FAM – P – Cha – G – Nva – HA – Dap(QXL® 520) – NH2 |
|
|
AS-60579-01 |
520 MMP FRET Substrate XII |
0.1 mg |
|
|
5 – FAM – RPKPYA – Nva – WM – K(QXL® 520) – NH2 |
|
|
AS-60580-01 |
520 MMP FRET Substrate XIII |
0.1 mg |
|
|
5 – FAM – RPKPVE – Nva – WRK(QXL® 520) – NH2 |
|
|
AS-60581-01 |
520 MMP FRET Substrate XIV |
0.1 mg |
|
|
QXL® 520 – 纬 – Abu – P – Cha – Abu – Smc – HA – Dab(5 – FAM) – AK – NH2 (Smc=S – Methyl – L – cysteine) |
|
|
AS-60582-01 |
520 MMP FRET Substrate XV |
0.1 mg |
|
|
QXL® 520 – 纬 – Abu – PQGL – Dab(5 – FAM) – AK – NH2 |
|
|
AS-60585-01 |
580 MMP FRET Substrate I |
0.1 mg |
|
|
QXL® 570 – KPLA – Nva – Dap(5 – TAMRA) – AR – NH2 |
|
|
AS-25350 |
T1 |
1 mg |
|
|
DABCYL – (纬 – Abu) – PQGL – E(EDANS)AK – NH2 |
|
|
AS-27096 |
MMP Colorimetric Substrate I |
1 mg |
|
|
Ac – PLG – SCH[CH2CH(CH3)2] – CO – LG – OC2H5 |
|
|
AS-27097 |
MMP Colorimetric Substrate I |
5 mg |
|
|
Ac – PLG – SCH[CH2CH(CH3)2] – CO – LG – OC2H5 |
|
|
AS-27114 |
NFF – 3 |
1 mg |
|
|
Mca – RPKPVE – Nva – WR – K(Dnp) – NH2 |
|
|
AS-60431-1 |
WAAG – 3R, Aggrecanase (ADAM – TS – 4) FRET Substrate |
1 mg |
|
|
Abz – TEGEARGSVI – Dpa – KK – NH2 |
|
|
AS-22991-025 |
HCV Protease FRET Substrate (RET S1) |
0.25 mg |
|
|
Ac – DE – D(Edans) – EE – Abu – 蠄 – [COO] – AS – K(Dabcyl) – NH2 |
|
|
AS-22991 |
HCV Protease FRET Substrate (RET S1) |
1 mg |
|
AS-22991-50 |
HCV Protease FRET Substrate (RET S1) |
50 mg |
|
|
Ac – DE – D(Edans) – EE – Abu – 蠄 – [COO] – AS – K(Dabcyl) – NH2 |
|
|
AS-22991-100 |
HCV Protease FRET Substrate (RET S1) |
100 mg |
|
|
Ac – DE – D(Edans) – EE – Abu – 蠄 – [COO] – AS – K(Dabcyl) – NH2 |
|
|
AS-22992 |
HIV Protease FRET Substrate I |
1 mg |
|
|
DABCYL – GABA – Ser – Gln – Asn – Tyr – Pro – Ile – Val – Gln – EDANS |
|
|
AS-85718 |
Dihydroethidium |
1 mL |
|
|
[Hydroethidine], 5 mM solution in DMSO |
|
|
AS-85728 |
Pentoxyresorufin |
5 mg |
|
|
[Resorufin pentyl ether] |
|